MannKind (MNKD) News Today $4.50 -0.02 (-0.33%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNKD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period MannKind to Present at Upcoming Investor ConferencesAugust 27 at 4:05 PM | globenewswire.comMannKind (NASDAQ:MNKD) Stock Price Down 5.2% - Here's What HappenedAugust 27 at 1:38 PM | marketbeat.comMannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled TherapyAugust 27 at 8:35 AM | markets.businessinsider.comMannKind Corporation Collaborates with United Therapeutics to Develop Second Dry Powder Inhalation TherapyAugust 27 at 8:31 AM | quiverquant.comQMannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled TherapyAugust 27 at 8:05 AM | globenewswire.comMannKind (NASDAQ:MNKD) Price Target Raised to $8.00August 27 at 2:06 AM | americanbankingnews.comSCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPHAugust 26 at 5:58 PM | businesswire.comVanguard Group Inc. Acquires 1,263,622 Shares of MannKind Corporation $MNKDAugust 26 at 3:04 AM | marketbeat.comMannKind Corporation (MNKD) Mergers and Acquisition Call TranscriptAugust 25 at 2:03 PM | seekingalpha.comMannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million DealAugust 25 at 1:57 PM | benzinga.comMannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value CreationAugust 25 at 12:10 PM | tipranks.comMannKind (MNKD) to Acquire scPharmaceuticals for $360 MillionAugust 25 at 11:31 AM | gurufocus.comMannKind’s Strategic Acquisition and Growth Prospects: A Buy Rating by Yun ZhongAugust 25 at 10:50 AM | tipranks.comMannKind to buy scPharmaceuticals to expand its cardiometabolic businessAugust 25 at 9:30 AM | seekingalpha.comMannKind to Buy ScPharmaceuticals for Up to $360 MillionAugust 25 at 8:41 AM | marketwatch.comShareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public ShareholdersAugust 25 at 8:31 AM | mms.businesswire.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25 at 8:30 AM | gurufocus.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25 at 8:30 AM | gurufocus.comMannKind Announces Acquisition of scPharmaceuticalsAugust 25 at 8:10 AM | tipranks.comscPharmaceuticals Announces Merger with MannKind CorporationAugust 25 at 8:10 AM | tipranks.comMannKind Corporation Announces Strategic Acquisition of scPharmaceuticals to Enhance Cardiorenal Medicine PortfolioAugust 25 at 7:51 AM | quiverquant.comQMannKind Corporation Announces Acquisition of scPharmaceuticals to Enhance Cardiorenal Portfolio and Accelerate Revenue GrowthAugust 25 at 7:51 AM | quiverquant.comQMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25 at 7:50 AM | gurufocus.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25 at 7:50 AM | gurufocus.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung DiseasesAugust 25 at 7:30 AM | globenewswire.comLeerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PTAugust 24, 2025 | finance.yahoo.comNuveen LLC Makes New $17.01 Million Investment in MannKind Corporation $MNKDAugust 23, 2025 | marketbeat.comLeerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PTAugust 22, 2025 | insidermonkey.comMannKind (NASDAQ:MNKD) Trading 4.3% Higher - What's Next?August 21, 2025 | marketbeat.comMannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies PipelineAugust 17, 2025 | insidermonkey.comMannKind Corporation (NASDAQ:MNKD) Given Consensus Recommendation of "Buy" by AnalystsAugust 14, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Sets New 12-Month Low - Should You Sell?August 13, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Position Decreased by Connor Clark & Lunn Investment Management Ltd.August 13, 2025 | marketbeat.comCantor Fitzgerald Decreases Earnings Estimates for MannKindAugust 11, 2025 | marketbeat.comCantor Fitzgerald Lowers Earnings Estimates for MannKindAugust 9, 2025 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for MannKind (NASDAQ:MNKD) Stock PriceAugust 8, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Sets New 52-Week Low - Here's What HappenedAugust 7, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | insidermonkey.comMannKind outlines $500M Blackstone financing while advancing Afrezza pediatric launch and IPF pipelineAugust 7, 2025 | msn.comMannKind Corporation Reports Q2 2025 Financial GrowthAugust 6, 2025 | tipranks.comDecoding MannKind Corp (MNKD): A Strategic SWOT InsightAugust 6, 2025 | gurufocus.comQ2 2025 MannKind Corp Earnings Call TranscriptAugust 6, 2025 | gurufocus.comMannKind Corporation (MNKD) Q2 2025 Earnings Conference Call TranscriptAugust 6, 2025 | seekingalpha.comMannKind Corporation: A Post-Q2 AssessmentAugust 6, 2025 | seekingalpha.comMannKind Corporation: A Post-Q2 AssessmentAugust 6, 2025 | seekingalpha.comPromising Outlook for MannKind: Buy Rating Justified by Clinical Progress and Financial StrengthAugust 6, 2025 | tipranks.comMannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 6, 2025 | gurufocus.comMannKind (MNKD) Shares Dip on Revenue Miss and Declining DemandAugust 6, 2025 | gurufocus.comMannKind stock falls after profit and revenue missAugust 6, 2025 | seekingalpha.comMannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 6, 2025 | globenewswire.com Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MNKD Media Mentions By Week MNKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼0.780.99▲Average Medical News Sentiment MNKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼316▲MNKD Articles Average Week Get the Latest News and Ratings for MNKD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MannKind and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Innoviva News Novavax News Dynavax Technologies News OPKO Health News Geron News Rigel Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share MannKind With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access